CME SPOTLIGHT SESSIONS

 

Neurotrophic Keratitis: Diagnosing and Treating a Rare Find!

Date: Thursday, August 25, 2022
Registration & Dinner: 6:00pm-6:30pm
CME Spotlight Session: 6:30pm-7:30pm

FACULTY:

Preeya K. Gupta, MD
Activity Chair
Managing Director
Triangle Eye Consultants
Raleigh, NC 
Adjunct Associate Professor of Ophthalmology Cornea, Cataract, & Refractive Surgery Tulane University
New Orleans, LA

Marjan Farid, MD
Clinical Professor of Ophthalmology
Director of Cornea, Cataract and Refractive Surgery
Gavin Herbert Eye Institute
University of California, Irvine
Irvine, CA

Learning Objectives:

  • Describe etiological factors associated with the development of neurotrophic keratitis.
  • Review diagnostic modalities that improve the early detection and staging of neurotrophic keratitis.
  • Assess the latest medical advances that target the treatment of neurotrophic keratitis.

Target Audience:

The intended audience for this activity is ophthalmologists and other health care professionals involved in the management of patients with or at risk for neurotrophic keratitis.

Provider Statement:

This continuing medical education activity is provided by Vindico Medical Education.

Supporter Statement:

This activity is supported by an educational grant from Dompé US, Inc.

Association Statement:

Held in conjunction with the Women in Ophthalmology (WIO) Summer Symposium.


Addressing an Age-old Condition: Novel Treatments for Presbyopia

Date: Friday, August 26, 2022
Registration & Breakfast: 6:45am-7:10am
CME Spotlight Session: 7:10am-8:10am

FACULTY:

Lisa M. Nijm, MD, JD 
Activity Chair
Founder, RealWorldOphthalmology.com
Founder, MDNegotiation.com
CEO, Women in Ophthalmology
Founder and Medical Director, Warrenville EyeCare and LASIK
Assistant Clinical Professor of Ophthalmology, University of Illinois Eye and Ear Infirmary
Chicago, IL

Sheri Rowen, MD, FACS
Medical Director
NVision Eye Centers
Newport Beach, CA
Clinical Assistant Professor
University of Maryland
Baltimore, MD

Learning Objectives:

  • Recognize the burden of presbyopia, as well as the benefits, limitations, and risks associated with conventional treatment options.
  • Examine new and emerging medical approaches for the treatment of presbyopia that may improve outcomes and patient satisfaction.

Target Audience:

The target audience for this activity is ophthalmologists and other health care professionals involved in the management of patients with presbyopia.

Provider Statement:

This continuing medical education activity is provided by Vindico Medical Education.

Supporter Statement:

This activity is supported by an educational grant from AbbVie Inc.

Association Statement:

Held in conjunction with the Women in Ophthalmology (WIO) Summer Symposium.


Exploring Thyroid Eye Disease With Eyes Wide Open

Date: Friday, August 26, 2022
Registration & Lunch: 11:50am-12:10pm
CME Spotlight Session: 12:10pm-1:10pm

FACULTY:

Sara Tullis Wester, MD, FACS
Activity Chair
Professor of Clinical Ophthalmology
Oculofacial Plastic and Reconstructive Surgery
Orbital Surgery and Oncology
Bascom Palmer Eye Institute
University of Miami Miller School of Medicine
Miami, FL

Penny A. Asbell MD, MBA, FARVO
Clinical Professor of Ophthalmology
University of Tennessee Health Science Center
Memphis, TN

Learning Objectives:

  • Describe the etiology and pathophysiology of thyroid eye disease, along with the burden it presents to patients.
  • Summarize modalities that aid in the early detection and diagnosis of thyroid eye disease, as well as measures that can be incorporated to ensure that the thyroid abnormality is controlled.
  • Compare currently available treatments for their efficacy, safety, and their ability to improve thyroid eye disease.

Target Audience:

The intended audience for this activity is ophthalmologists and other health care professionals involved in the management of patients with thyroid eye disease.

Provider Statement:

This continuing medical education activity is provided by Vindico Medical Education.

Supporter Statement:

This activity is supported by an educational grant from Horizon Therapeutics USA, Inc.

Association Statement:

Held in conjunction with the Women in Ophthalmology (WIO) Summer Symposium.


NOVEL SOLUTIONS TO PRESSING PROBLEMS: MITIGATING TREATMENT BURDEN IN nAMD AND DME

Date: Saturday, August 27, 2022
Registration & Lunch: 12:30pm-12:45pm
CME Spotlight Session: 12:45pm-1:45pm

FACULTY:

Margaret A. Chang, MD, MS
Activity Chair
Senior Partner
Retinal Consultants of Sacramento
Sacramento, CA

Christina Y. Weng, MD, MBA
Professor of Ophthalmology
Fellowship Program Director, Vitreoretinal Diseases & Surgery
Baylor College of Medicine
Houston, TX

Learning Objectives:

  • Examine currently available injectables that lengthen dosing intervals in the treatment of neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME).
  • Assess new and emerging surgical therapies that can reduce reliance on frequent anti-VEGF (vascular endothelial growth factor) injections in patients with nAMD or DME.

Target Audience:

The intended audience for this activity is ophthalmologists and other health care professionals involved in the management of patients with neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME).

Provider Statement:

This continuing medical education activity is provided by Vindico Medical Education.

Supporter Statement:

This activity is supported by an educational grant from Genentech, a member of the Roche Group.

Association Statement:

Held in conjunction with the Women in Ophthalmology (WIO) Summer Symposium.